Association of hepatitis C virus and hepatitis B virus in chronic liver disease

Indian Journal of Medical Research

Volumn 108, Issue DEC., 1998, Pages 255-259

  Berry, N ^d   Chakravarti, A ^a,d   Kar, P ^a   Das, B C ^b   Santhanam, ^c   Mathur, M D ^d  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^d Department of Microbiology ^*  (India)

Author keywords

Anti HCV antibody; Chronic liver disease; Hepatitis B virus; Hepatitis C virus; Reverse transcription polymerase chain reaction (RT PCR)

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED;

EID: 0032439764     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gupta H, Irshad M, Joshi YK, Acharya SK, Tandon BN. Hepatitis C virus antibody in acute and chronic liver diseases in India (letter). Scand J Infect Dis 1990; 22 : 627.
2. Ramesh R, Munshi A, Panda SK. Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol 1992; 7 : 393-5.
3. Das MR, Ali N, Aruna B, Durga R, Nambiar A, Rehana Z, et al. Indian strains of hepatitis-C-virus : Prevalence and detection. Curr Sci 1993; 65 : 477-83.
4. Amarapurkar DN, Kumar A, Parikh SS, Chopra KB, Murti P, Kalro RH, et al. Hepatitis C virus infection in chronic liver disease in Bombay. Indian J Gastroenterol 1992; 11 : 162-3.
5. Irshad M, Acharya SK, Joshi YK. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Delhi. Indian J Med Res 1995; 102 : 162-4.
6. Panigrahi AK, Nanda SK, Dixit RK, Acharya SK, Zuckerman AJ, Panda SK. Diagnosis of hepatitis C virus-associated chronic liver disease in India : Comparison of HCV antibody assay with a polymerase chain reaction for the 5′ non coding region. J Med Virol 1994; 44 : 176-9.
7. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, et al. A long term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325 : 98-104.
8. Pawlotsky JM, Fleury A, Choukroun V, Deforges L, Roudot-Thoraval F, Aumont P, et al. Significance of highly positive c22-3 'indeterminate' second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol 1994; 32 : 1357-9.
9. Weiland O, Schvarcz R. Hepatitis C: Virology, epidemiology, clinical course and treatment. Scand J Gastroenterol 1992; 27 : 337-42.
10. Ishak K, Baptista A, Bianchi L, Callea F, Groote JD, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22 : 696-9.
11. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978; 31 : 395-414.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 1987; 162 : 156-9.
13. Garson JA, Ring C, Tuke P, Teddar RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 1990; 336 : 878-9.
14. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems : first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992; 16 : 300-5.
15. Schmidt WN, Wu P, Cederna J, Mitros FA, La Brecque DR, Stapleton JT. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 1997; 176 : 27-33.
16. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease : The Taiwan experience. J Infect Dis 1990; 162 : 817-22.
17. Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981; 246 : 630-4.
18. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, et al. Serum alanine aminotransferase of donors in relation to the risk on non A, non B hepatitis in recipients : the transfusion transmitted viruses study. N Engl J Med 1981; 304 : 989-94.
19. van der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990; 335 : 558-60.
20. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244 : 359-62.